May 13, 2025
An artificial intelligence (AI) model using routinely collected data predicted subsequent development of active tuberculosis (TB), Swiss researchers reported. The AI model outperformed biological tests for […]
May 7, 2025
TOPLINE: Long-acting antiretroviral therapy (LA-ART) maintained high viral suppression for 48 weeks in patients with HIV regardless of initial viremia. METHODOLOGY: Researchers examined viral suppression for […]
May 6, 2025
TOPLINE: AIDS-related illnesses continued to be the leading cause of hospitalization, accounting for 42% of the admissions, with tuberculosis being the most frequent illness. This pattern […]
April 28, 2025
The legacy of discriminatory housing policies continues to shape both economic and health outcomes. A study by Tulane University, New Orleans, published in JAMA Internal Medicine, […]
April 23, 2025
TOPLINE: Long-acting injectable HIV treatment led to rectal shedding in nearly 15% of patients with HIV, independent of the oral lead-in phase. A high pretreatment viral […]
April 16, 2025
Pre-exposure prophylaxis (PrEP) for HIV is a highly effective tool for preventing HIV transmission in all populations and countries. However, despite being approved and available by […]
April 8, 2025
According to a study published in The Lancet HIV, recent and planned international budget cuts could result in 4.4-10.8 million new HIV infections by 2030 in […]
April 8, 2025
The latest federal funding cuts are already affecting progress against HIV, according to a panel of experts at a briefing hosted by the Infectious Diseases Society […]
March 31, 2025
TOPLINE: The modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine was safe and well tolerated and offered protection against mpox in people living with HIV, individuals on HIV […]